![William F. Hahne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
William F.
Hahne worked as an Executive Director of Clinical Research at Eisai, Inc. from 1997 to 2002.
He then served as a Vice President of Medical at Vion Pharmaceuticals, Inc. After that, he held the position of VP of Clinical Development & Medical Affairs at Imunon, Inc. from 2006 to 2007.
Prior to that, he was a Vice President of Clinical Development at CuraGen Corp.
from 2003 to 2005.
He also worked as a Vice President of Clinical Development at CuraGen Corp.
and as a Vice President of Clinical Research at Bio-Path Holdings, Inc. Dr. Hahne completed his undergraduate degree at Grinnell College and obtained a doctorate degree from Cornell University.
Former positions of William F. Hahne
Companies | Position | End |
---|---|---|
IMUNON, INC. | Chief Tech/Sci/R&D Officer | 30/11/2007 |
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Chief Tech/Sci/R&D Officer | 31/12/2004 |
Eisai, Inc.
![]() Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Chief Tech/Sci/R&D Officer | 31/12/2001 |
BIO-PATH HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Vion Pharmaceuticals, Inc.
![]() Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Chief Tech/Sci/R&D Officer | - |
Training of William F. Hahne
Cornell University | Doctorate Degree |
Grinnell College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
IMUNON, INC. | Health Technology |
BIO-PATH HOLDINGS, INC. | Health Technology |
Private companies | 3 |
---|---|
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Vion Pharmaceuticals, Inc.
![]() Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
Eisai, Inc.
![]() Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
- Stock Market
- Insiders
- William F. Hahne